Hanna M Tolonen

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Smoking Cessation

Minimally Invasive

General Practice

Peritoneal Dialysis

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Helsinki

Finland

PHD :: Pharmacy

University of Eastern Finland

Finland

MSC

Publications

Saana V Luukkanen, Hanna M Tolonen, Marja Airaksinen, Laura S M Kuula
The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in Finland. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (4) (2022)
Hanna M Tolonen, Jenni Falck, Pekka Kurki, Päivi Ruokoniemi, Katri Hämeen-Anttila, Kenneth M Shermock, Marja Airaksinen
Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (5) (2021)
Hanna M Tolonen, Marja Sa Airaksinen, Päivi Ruokoniemi, Katri Hämeen-Anttila, Kenneth M Shermock, Pekka Kurki
Medication safety risks to be managed in national implementation of automatic substitution of biological medicines: a qualitative study. BMJ open 9 (10) (2019)